Derivatives of hydroxamic acid as metalloproteinase inhibitors
US7786121B2 · kind B2 · utility
2Cited by
2References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 18, 2004 |
| Grant date | Aug 31, 2010 |
| Priority date | — |
| Expiry date | Nov 26, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D333/34
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of formula (I), or an enantiomer or diastereoisomer thereof, or a salt, hydrate or solvate thereof:for the treatment or prophylaxis of arthritis in mammals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.